Check out "Building Biotech Startups - How to Start?" eventbrite.com/e/building-bio… @Eventbrite

.@SyntheX_Labs, incubated at IndieBio, is accelerating #drugdiscovery using #syntheticbiology: using a cell-based platform, they select targeted compounds that modulate protein interactions. Learn more with Maria Soloveychik at #SynBioBeta2018 buff.ly/2t9D9HJ #synbio

Join our #synbiobeta2018 session on how #synbio has become the cutting edge in #pharma & #healthcare w/ @OxfordGenetics, Maria Soloveychik @SyntheX_Labs, David Younger A-Alpha Bio, eGenesis, Melanie Matheu, PhD @PrellisBio @dmtxbio Scaled Biolabs bit.ly/2pi9SbA

Many potentially great drug targets are hard to modulate pharmacologically — but nature has ways to modulate almost every protein, so let’s learn from nature how to design peptide-based drugs - Maria Soloveychik of SyntheX at #SynBioBeta2018

The best way to predict the future is to create it. IndieBio @SOSVvc Arvind Gupta

Tune In! We loved having Maria Soloveychik SyntheX on Season 2 of #IndieBio #DesigningScience podcast w/ Arvind Gupta! #Biotech #Founders Jun Axup Penman @Aexkopelyan @SOSVvc podcasts.apple.com/us/podcast/arv…

Interview with the C.E.O. SyntheX How do they identify relevant drug targets based on clinical, evolutionary, and phenotypic features? They use an evolutionary cell-based platform to select targeted compounds that modulate protein-protein interactions buff.ly/2Gutq5n

Tune into Season 2 of Designing Science w/ Arvind Gupta Rick Doblin, Ph.D., of MAPS SyntheX Prellis Biologics @catalogdna Maria Soloveychik Melanie Matheu, PhD Flow Genome Project #IndieBio @SOSVvc podcasts.apple.com/us/podcast/ind…

#IndieBio alumni dinner! Happy summer from @NewAgeMeats Prime Roots Guided Clarity @ClaraFoods Endless West BioAesthetics @tinctoriumbio Pheronym @sugarlogix Convalesce SyntheX Jungla Inc. Geltor Inc. NovoNutrients: food & feed from CO2™ @SOSVvc AlexKopelyan Jun Axup Penman Parikshit Sharma

Interested to learn how #yeast, #genetics, and #syntheticbiology can drive #drugdiscovery? Listen to Maria Soloveychik, Co-Founder & CEO, of SyntheX to understand their platform to modulate protein interactions. bit.ly/3moZpYa #womeninscience #biotech #cancer

Nice profile of some great companies in the #synbio and programmable medicines space! Mammoth Biosciences SyntheX ArsenalBio CHAINBiotech Love seeing this ecosystem grow! 🧬💻🧪 genengnews.com/topics/genome-…

Congrats to SyntheX and CEO Maria Soloveychik on inking a partnership with Bristol Myers-Squibb in a deal worth up to $550M to develop targeted protein degraders. Proud to have supported the founders from IndieBio to today endpts.com/bristol-myers-…

We are thrilled to announce a research collaboration with Bristol Myers Squibb, Bristol Myers Squibb, to discover and develop targeted protein degradation therapies! This collaboration leverages our ToRNeDO platform to discover novel molecular glues. Learn more here! prn.to/3Rzt5Qw

Congratulations to Maria Soloveychik (Maria Soloveychik) and the team at SyntheX, which announced a $550 million research collaboration with Bristol Myers-Squibb to develop better cancer drugs with SyntheX’s drug discovery platforms. indiebio.co/ventures-rule-…

“We’re particularly excited because molecular glues are kind of unknown—there are no rules" BMS enters lawless land of molecular degraders with $550M SyntheX deal fiercebiotech.com/biotech/bms-en… #lifesciences #partnering

Today we launched our second PerlQuest partnership! That brings our total number of partnerships to three - all signed in Q4.

Peptide hydrogels for wound healing! pnas.org/content/113/40…

Proud to be part of the SOSV - Deep Tech for Human and Planetary Health IndieBio family! #skydive17 x.com/SOSVvc/status/…

Happy holidays from the @SyntheX_Labs team! #2018

Proud of the work we're doing at @SyntheX_Labs with our fantastic scientists. And grateful to be surrounded by the support of the amazing JLABS team. #womeninSTEM #IWD2018 x.com/JLABS/status/9… x.com/JLABS/status/9…